Search

everythinglearnresearchcommunity

for

Search:↓

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

Some cancer treatments can cause permanent hair loss.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Yoga and Ayurveda, including stress management and herbal oil use, can potentially reduce hair loss and promote hair growth, with further research needed for therapy protocols.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Higher doses of cranial irradiation are linked to permanent hair loss.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.